REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Andersen Pharma Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Advertising Agencies
Full name: Andersen Pharma Poland Sp. z o.o. Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Andersen Pharma Poland Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. Andersen Pharma Poland Sp. z o.o. was incorporated on April 20, 2018. From the latest financial highlights, Andersen Pharma Poland Sp. z o.o. reported a net sales revenue drop of 8.93% in 2023. Its’ total assets recorded a growth of 14.42%. The net profit margin of Andersen Pharma Poland Sp. z o.o. decreased by 20.81% in 2023.

Headquarters
Ul. Domaniewska 47/10
Warsaw; Mazowieckie; Postal Code: 02-672

Contact Details: Purchase the Andersen Pharma Poland Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Andersen Pharma Poland Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Andersen Pharma Poland Sp. z o.o. report to view the information.
Incorporation Date:
April 20, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Andersen Pharma Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-8.93%▼
Total operating revenue
-68.15%▼
Operating profit (EBIT)
-51.56%▼
Net Profit (Loss) for the Period
-60.03%▼
Total assets
14.42%▲
Total equity
18.72%▲
Operating Profit Margin (ROS)
-20.14%▼
Net Profit Margin
-20.81%▼
Return on Equity (ROE)
-31.06%▼
Quick Ratio
19.86%▲
Cash Ratio
18.13%▲

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
"Cobrabid - Optica" Sp. z o.o.
 
Innosil Sp. z o.o.
Fcbiotech S.A.
 
Fundacja Polskich Inicjatyw Technologicznych
Luna Laboratory Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo